Area of research
Immunology · Infectious Diseases · mRNA vaccine · mRNA Vaccines
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, COVID-19 Clinical Research Studies, and T-cell and B-cell Immunology.
Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells